<code id='E3FF57F8E5'></code><style id='E3FF57F8E5'></style>
    • <acronym id='E3FF57F8E5'></acronym>
      <center id='E3FF57F8E5'><center id='E3FF57F8E5'><tfoot id='E3FF57F8E5'></tfoot></center><abbr id='E3FF57F8E5'><dir id='E3FF57F8E5'><tfoot id='E3FF57F8E5'></tfoot><noframes id='E3FF57F8E5'>

    • <optgroup id='E3FF57F8E5'><strike id='E3FF57F8E5'><sup id='E3FF57F8E5'></sup></strike><code id='E3FF57F8E5'></code></optgroup>
        1. <b id='E3FF57F8E5'><label id='E3FF57F8E5'><select id='E3FF57F8E5'><dt id='E3FF57F8E5'><span id='E3FF57F8E5'></span></dt></select></label></b><u id='E3FF57F8E5'></u>
          <i id='E3FF57F8E5'><strike id='E3FF57F8E5'><tt id='E3FF57F8E5'><pre id='E3FF57F8E5'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:4279

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Medicare must police algorithms in Medicare Advantage, Dems say
          Medicare must police algorithms in Medicare Advantage, Dems say

          Reps.JerryNadler(D-N.Y.)andJudyChu(D-Calif.)JoshuaRoberts/GettyImagesHouseDemocratsareraisingconcern

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Readout LOUD podcast: The Sarepta saga, decoding biotech hype

          Whenisafailurenotafailure?DoestheFDAhavespecialrulesforSareptaTherapeutics?Andhowdoyousay“brash”inFr